[ORGANIZATION]
Sandoz
Featured in 5 tracked stories · first seen
Situations
European and global market volatility
3 clusters · 12 sources · last updated
Latest: FTSE 100 expected to decline amid US inflation concerns
European equity markets, specifically the FTSE 100, experienced a period of volatility and a six-session losing streak driven by weakness in consumer-facing sectors, rising oil prices, and geopolitical uncertainty in the
Expansion of semaglutide generic and biosimilar markets
2 clusters · 12 sources · last updated
Latest: Sandoz targets biosimilar growth and generic semaglutide expansion
The pharmaceutical market for semaglutide-based medications is expanding through the introduction of generic and biosimilar alternatives. In Brazil, the National Health Surveillance Agency (Anvisa) approved new injectabl
Also covered in
-
Sandoz and Henlius Biotech sign $322 million biosimilar deal
[BUSINESS] · 12 sources ·
-
Swiss pharma firms Sandoz and Galenica post solid first‑half growth
[BUSINESS] · 3 sources ·
-
Sandoz to Pay $450 Million in Settlement with 43 U.S. States
[BUSINESS] · 4 sources ·